THÔNG TIN TÀI LIỆU
cardiomyopathy Circulation 2003;107(22):2850–2856 138 Hinson JT, Chopra A, Lowe A, et al Integrative analysis of PRKAG2 cardiomyopathy iPS and microtissue models identifies AMPK as a regulator of metabolism, Survival, and fibrosis Cell Rep 2016;17(12):3292–3304 139 Kim M, Hunter RW, Garcia-Menendez L, et al Mutation in the gamma2-subunit of AMPactivated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage Circ Res 2014;114(6):966–975 140 Zhang LP, Hui B, Gao BR High risk of sudden death associated with a PRKAG2-related familial Wolff-parkinson-white syndrome J Electrocardiol 2011;44(4):483–486 141 Akman HO, Sampayo JN, Ross FA, et al Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase Pediatr Res 2007;62(4):499– 504 142 Sternick EB, Oliva A, Gerken LM, et al Clinical, electrocardiographic, and electrophysiologic characteristics of patients with a fasciculoventricular pathway: the role of PRKAG2 mutation Heart Rhythm 2011;8(1):58–64 143 Limongelli G, Tome-Esteban M, Dejthevaporn C, et al Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease Eur J Heart Fail 2010;12(2):114–121 144 Bates MG, Nesbitt V, Kirk R, et al Mitochondrial respiratory chain disease in children undergoing cardiac transplantation: a prospective study Int J Cardiol 2012;155(2):305–306 145 Yaplito-Lee J, Weintraub R, Jamsen K, et al Cardiac manifestations in oxidative phosphorylation disorders of childhood J Pediatr 2007;150(4):407–411 146 Scaglia F, Towbin JA, Craigen WJ, et al Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease Pediatrics 2004;114(4):925–931 147 Debray FG, Lambert M, Chevalier I, et al Longterm outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases Pediatrics 2007;119(4):722–733 148 Holmgren D, Wahlander H, Eriksson BO, et al Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings Eur Heart J 2003;24(3):280–288 149 Vydt TC, de Coo RF, Soliman OI, et al Cardiac involvement in adults with m.3243a>G MELAS gene mutation Am J Cardiol 2007;99(2):264– 269 150 Malfatti E, Laforet P, Jardel C, et al High risk of severe cardiac adverse events in patients with mitochondrial m.3243a>G mutation Neurology 2013;80(1):100–105 151 Child JS, Perloff JK, Bach PM, et al Cardiac involvement in Friedreich's ataxia: a clinical study of 75 patients J Am Coll Cardiol 1986;7(6):1370–1378 152 Isnard R, Kalotka H, Durr A, et al Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia Circulation 1997;95(9):2247–2249 153 Casazza F, Morpurgo M The varying evolution of Friedreich's ataxia cardiomyopathy Am J Cardiol 1996;77(10):895–898 154 Campuzano V, Montermini L, Molto MD, et al Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion Science 1996;271(5254):1423–1427 155 Durr A, Cossee M, Agid Y, et al Clinical and genetic abnormalities in patients with Friedreich's ataxia N Engl J Med ... spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease Pediatrics 2004;114(4):925–931 147 Debray FG, Lambert M, Chevalier I, et al Longterm outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases... Debray FG, Lambert M, Chevalier I, et al Longterm outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases Pediatrics 2007;119(4):722–733 148 Holmgren D, Wahlander H, Eriksson BO, et al Cardiomyopathy in children with mitochondrial
Ngày đăng: 22/10/2022, 12:42
Xem thêm: